Similarly, another recent study [42] used breast cancer cell lines to show how BRCA1/IFN-γ pathways may regulate target genes involved in innate immune response, providing another possible mechanism for tumor intrinsic IR gene expression variability. The gene discussed is BRCA1; the disease is breast carcinoma.